Search research articles
Contact Us
Filters
Showing results (151-160 of 403) with videos related to
Page
of 41
Sort By:
Rheumatology (Oxford, England)
|
November 29, 2014
Head-to-toe whole-body MRI in psoriatic arthritis, axial spondyloarthritis and healthy subjects: first steps towards global inflammation and damage scores of peripheral and axial joints
René Panduro Poggenborg, Susanne Juhl Pedersen, Iris Eshed, et al.
Clinical Drug Investigation
|
January 27, 2020
Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS)
Xenofon Baraliakos, Mikkel Østergaard, Lianne S Gensler, et al.
Arthritis Research & Therapy
|
February 1, 2021
Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission
Lene Terslev, Cecilie Heegaard Brahe, Mikkel Østergaard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 4, 2019
Comparative Effectiveness of Certolizumab Pegol, Abatacept, and Biosimilar Infliximab in Patients With Rheumatoid Arthritis Treated in Routine Care: Observational Data From the Danish DANBIO Registry Emulating a Randomized Trial
Kathrine L Grøn, Bente Glintborg, Mette Nørgaard, et al.
BMC Rheumatology
|
March 1, 2024
Patients' experience of a novel interdisciplinary nurse-led self-management intervention (INSELMA)-a qualitative evaluation
Nadine Schäffer Blum, Bente Appel Esbensen, Mikkel Østergaard, et al.
The Lancet. Rheumatology
|
January 30, 2024
Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis
Walter P Maksymowych, Xenofon Baraliakos, Robert G Lambert, et al.
EULAR Rheumatology Open
|
June 29, 2026
Feasibility of INSELMA: an interdisciplinary nurse-coordinated self-management intervention for people with inflammatory arthritis and substantial disease impact
Nadine Schäffer Blum, Bente Appel Esbensen, Ann Bremander, et al.
Cytokine
|
March 8, 2017
Expression of soluble CD83 in plasma from early-stage rheumatoid arthritis patients is not modified by anti-TNF-α therapy
Anne-Mette Kristensen, Kristian Stengaard-Pedersen, Merete Lund Hetland, et al.
Rheumatology (Oxford, England)
|
March 25, 2014
Bone marrow oedema assessment by magnetic resonance imaging in rheumatoid arthritis wrist and metacarpophalangeal joints: the importance of field strength, coil type and image resolution
Simon Krabbe, Iris Eshed, Susanne Juhl Pedersen, et al.
Clinical and Experimental Rheumatology
|
May 13, 2015
Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs
Stinne Ravn Greisen, Holger Jon Møller, Kristian Stengaard-Pedersen, et al.
Page
of 41
Search research articles
Search
Showing results (151-160 of 403) with videos related to
Sort By:
Page
of 41
Rheumatology (Oxford, England)
|
November 29, 2014
Head-to-toe whole-body MRI in psoriatic arthritis, axial spondyloarthritis and healthy subjects: first steps towards global inflammation and damage scores of peripheral and axial joints
René Panduro Poggenborg, Susanne Juhl Pedersen, Iris Eshed, et al.
Clinical Drug Investigation
|
January 27, 2020
Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS)
Xenofon Baraliakos, Mikkel Østergaard, Lianne S Gensler, et al.
Arthritis Research & Therapy
|
February 1, 2021
Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission
Lene Terslev, Cecilie Heegaard Brahe, Mikkel Østergaard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 4, 2019
Comparative Effectiveness of Certolizumab Pegol, Abatacept, and Biosimilar Infliximab in Patients With Rheumatoid Arthritis Treated in Routine Care: Observational Data From the Danish DANBIO Registry Emulating a Randomized Trial
Kathrine L Grøn, Bente Glintborg, Mette Nørgaard, et al.
BMC Rheumatology
|
March 1, 2024
Patients' experience of a novel interdisciplinary nurse-led self-management intervention (INSELMA)-a qualitative evaluation
Nadine Schäffer Blum, Bente Appel Esbensen, Mikkel Østergaard, et al.
The Lancet. Rheumatology
|
January 30, 2024
Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis
Walter P Maksymowych, Xenofon Baraliakos, Robert G Lambert, et al.
EULAR Rheumatology Open
|
June 29, 2026
Feasibility of INSELMA: an interdisciplinary nurse-coordinated self-management intervention for people with inflammatory arthritis and substantial disease impact
Nadine Schäffer Blum, Bente Appel Esbensen, Ann Bremander, et al.
Cytokine
|
March 8, 2017
Expression of soluble CD83 in plasma from early-stage rheumatoid arthritis patients is not modified by anti-TNF-α therapy
Anne-Mette Kristensen, Kristian Stengaard-Pedersen, Merete Lund Hetland, et al.
Rheumatology (Oxford, England)
|
March 25, 2014
Bone marrow oedema assessment by magnetic resonance imaging in rheumatoid arthritis wrist and metacarpophalangeal joints: the importance of field strength, coil type and image resolution
Simon Krabbe, Iris Eshed, Susanne Juhl Pedersen, et al.
Clinical and Experimental Rheumatology
|
May 13, 2015
Macrophage activity assessed by soluble CD163 in early rheumatoid arthritis: association with disease activity but different response patterns to synthetic and biologic DMARDs
Stinne Ravn Greisen, Holger Jon Møller, Kristian Stengaard-Pedersen, et al.
Page
of 41